跳至主要内容
临床试验/EUCTR2008-000832-42-GB
EUCTR2008-000832-42-GB进行中(未招募)1 期

Effectiveness of Heliox in Hypercapnic Respiratory Failure

East Kent Hospital Trust0 个研究点目标入组 68 人开始时间: 2008年6月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. All patients with hypercapnic respiratory failure due to exacerbations of COPD admitted to A&E/ CDU at the William Harvey Hospital will be considered for the study.
  • Patients therefore need to be
  • 1)Acidotic ( arterial blood gas pH < 7.35) due to high blood carbon dioxide
  • 2)Have a formal diagnosis of COPD
  • 3)Be admitted with an exacerbation of COPD
  • 4) PO2 < 8kpa
  • 5) PCO2 > 7kpa
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Patients deemed not competent to make a decision about consent for the study by the admitting doctor based on Abbreviated Mental Test Score < 7 out of 10
  • 2) Patients who are comatose / drowsy on admission and unable to communicate
  • 3) Patients requiring immediate NIV or Intubation at time of assessment by member of research team / Medical Registrar. ( In some situations patients may have had delay in assessment by A&E staff or have received controlled oxygen therapy by paramedics . If these patients are deteriorating when assessed they will be excluded and started on immediate NIV)
  • 4) Have hypercapnic respiratory failure for a reason other than COPD exacerbation
  • 5) Do not understand verbal/ written information in English

研究者

发起方
East Kent Hospital Trust

相似试验